GGrantIndex
Sort

40,608 grants matching prostate cancer

Endothelin Mechanisms in Metastic Prostate Cancer Pain

$394,182
Gary R Strichartz · Brigham And Women'S Hospital · R01 · FY2013 · CA

Race-related alternative splicing: novel targets in prostate cancer

$394,176
Steven R Patierno · Duke University · R01 · FY2018 · CA

Increasing Thiols for Improving T cell Immunotherapy

$394,167
Shikhar Mehrotra · Lipo-Immuno Tech, Llc · R41 · FY2022 · CA

Chip NMR biosensor for molecular analysis of cells

$394,128
Ralph Weissleder · Massachusetts General Hospital · R01 · FY2010 · EB

Administrative Supplement

$394,072
Robert C. Hornik · University Of Pennsylvania · P20 · FY2012 · CA

High Resolution 3-D Imaging of Molecular Beacons

$393,903
Optical Devices, Inc. · R44 · FY2004 · CA

The Role of Fgf Signaling in Vertebrate Development

$393,865
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA

$393,833
Thomas Jefferson University · R01 · FY2000 · CA

IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen

$393,773
Hongjiao Ouyang · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA

Suicide Gene and Radiation Therapy Clinical Trials

$393,755
Henry Ford Health System · P01 · FY2004 · CA

GENETIC CLONAL DIVERSITY AS BIOMARKER FOR AGGRESSIVE GLEASON 7 PROSTATE CANCER

$393,750
Dana-Farber Cancer Institute, Inc. · · FY2012 · Department of the Army

A novel implantable drug-eluting device that delivers an anti-androgen to the prostate to treat localized early stage prostate cancer

$393,713
Maithili Rairkar · Alessa Therapeutics, Inc. · R43 · FY2021 · CA

Micro Ultrasound Scanner to Track Tumor Models

$393,698
Kenneth P Olive · Columbia University Health Sciences · S10 · FY2011 · RR

A COMPREHENSIVE ASSESSMENT OF POLYMORPHISMS IN ANTIOXIDANT DEFENSE GENES AND THEIR INTERACTIONS WITH OXIDATIVE STRESS IN PROSTATE CANCER RISK AND SUR

$393,623
Glaxosmithkline, Llc · · FY2008 · Department of Defense

Highly Sensitive Chemical Microscopy by Probing the Thermal Effect of Infrared Light

$393,601
Ji-Xin Cheng · Boston University (Charles River Campus) · R01 · FY2019 · GM

Immune-inflammatory signaling and hormone-refractory prostate cancer evolution.

$393,505
Jun-Li Luo · Scripps Research Institute, The · R01 · FY2014 · CA

NORTHERN NEW JERSY COMMUNITY ONCOLOGY PROGRAM

$393,503
Hackensack University Medical Center · U10 · FY2000 · CA

Subcellular Distribution & Regulation of ala-Adrenocepto

$393,495
Debra A. Schwinn · University Of Washington · R37 · FY2008 · HL

Tumor-Activated Dual Payload-Drug Conjugates

$393,401
Clifford Berkman · Washington State University · R21 · FY2024 · CA

PROTACs for pancreatic cancer therapy

$393,400
Amarnath Natarajan · University Of Nebraska Medical Center · R21 · FY2020 · CA

Cancer Center Support Grant

$393,389
University Of California San Francisco · P30 · FY2002 · CA

Restless Legs Syndrome, Cardiovascular Risk Factors, and Cardiovascular Events

$393,355
Tobias Kurth · Brigham And Women'S Hospital · R01 · FY2010 · HL

PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics

$393,306
Martin G Pomper · Johns Hopkins University · U01 · FY2017 · CA

PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening

$393,276
Judith Mary Eileen Walsh · University Of California, San Francisco · R01 · FY2013 · CA

A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis

$393,213
James P Quigley · Scripps Research Institute, The · R01 · FY2009 · CA